vs
Innovex International, Inc.（INVX）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Innovex International, Inc.的1.4倍（$382.2M vs $273.6M），Innovex International, Inc.净利率更高（5.1% vs 3.1%，领先2.1%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 9.1%），过去两年Innovex International, Inc.的营收复合增速更高（46.2% vs 12.8%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
INVX vs LFST — 直观对比
营收规模更大
LFST
是对方的1.4倍
$273.6M
营收增速更快
LFST
高出8.3%
9.1%
净利率更高
INVX
高出2.1%
3.1%
两年增速更快
INVX
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.6M | $382.2M |
| 净利润 | $14.0M | $11.7M |
| 毛利率 | 28.9% | — |
| 营业利润率 | 9.4% | 4.7% |
| 净利率 | 5.1% | 3.1% |
| 营收同比 | 9.1% | 17.4% |
| 净利润同比 | -56.1% | 264.1% |
| 每股收益（稀释后） | $0.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INVXLFST
| Q4 25 | $273.6M | $382.2M | ||
| Q3 25 | $240.0M | $363.8M | ||
| Q2 25 | $224.2M | $345.3M | ||
| Q1 25 | $240.4M | $333.0M | ||
| Q4 24 | $250.7M | $325.5M | ||
| Q3 24 | $151.8M | $312.7M | ||
| Q2 24 | $130.3M | $312.3M | ||
| Q1 24 | $128.0M | $300.4M |
净利润INVXLFST
| Q4 25 | $14.0M | $11.7M | ||
| Q3 25 | $39.2M | $1.1M | ||
| Q2 25 | $15.3M | $-3.8M | ||
| Q1 25 | $14.8M | $709.0K | ||
| Q4 24 | $31.8M | $-7.1M | ||
| Q3 24 | $82.6M | $-6.0M | ||
| Q2 24 | $9.5M | $-23.3M | ||
| Q1 24 | $16.4M | $-21.1M |
毛利率INVXLFST
| Q4 25 | 28.9% | — | ||
| Q3 25 | 31.6% | — | ||
| Q2 25 | 32.0% | — | ||
| Q1 25 | 31.8% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 34.7% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 38.4% | — |
营业利润率INVXLFST
| Q4 25 | 9.4% | 4.7% | ||
| Q3 25 | 26.0% | 2.0% | ||
| Q2 25 | 10.1% | -0.9% | ||
| Q1 25 | 9.1% | 0.5% | ||
| Q4 24 | 10.7% | 0.3% | ||
| Q3 24 | -8.7% | 0.0% | ||
| Q2 24 | 10.0% | -5.1% | ||
| Q1 24 | 17.4% | -5.6% |
净利率INVXLFST
| Q4 25 | 5.1% | 3.1% | ||
| Q3 25 | 16.3% | 0.3% | ||
| Q2 25 | 6.8% | -1.1% | ||
| Q1 25 | 6.1% | 0.2% | ||
| Q4 24 | 12.7% | -2.2% | ||
| Q3 24 | 54.4% | -1.9% | ||
| Q2 24 | 7.3% | -7.5% | ||
| Q1 24 | 12.8% | -7.0% |
每股收益（稀释后）INVXLFST
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.57 | — | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $0.21 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $1.99 | — | ||
| Q2 24 | $0.30 | — | ||
| Q1 24 | $0.51 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $248.6M |
| 总债务越低越好 | $18.9M | $282.8M |
| 股东权益账面价值 | $1.1B | $1.5B |
| 总资产 | $1.3B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资INVXLFST
| Q4 25 | — | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | — | $154.6M | ||
| Q3 24 | — | $102.6M | ||
| Q2 24 | $185.6M | $87.0M | ||
| Q1 24 | $202.2M | $49.5M |
总债务INVXLFST
| Q4 25 | $18.9M | $282.8M | ||
| Q3 25 | $20.1M | $284.6M | ||
| Q2 25 | $34.8M | $286.4M | ||
| Q1 25 | $19.7M | $288.2M | ||
| Q4 24 | $24.9M | $290.0M | ||
| Q3 24 | $12.4M | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
股东权益INVXLFST
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.5B | ||
| Q2 25 | $995.6M | $1.5B | ||
| Q1 25 | $978.4M | $1.5B | ||
| Q4 24 | $958.2M | $1.4B | ||
| Q3 24 | $904.4M | $1.4B | ||
| Q2 24 | $352.5M | $1.4B | ||
| Q1 24 | $344.3M | $1.4B |
总资产INVXLFST
| Q4 25 | $1.3B | $2.2B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.1B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.0B | $2.1B | ||
| Q1 24 | $1.0B | $2.1B |
负债/权益比INVXLFST
| Q4 25 | 0.02× | 0.19× | ||
| Q3 25 | 0.02× | 0.19× | ||
| Q2 25 | 0.03× | 0.19× | ||
| Q1 25 | 0.02× | 0.20× | ||
| Q4 24 | 0.03× | 0.20× | ||
| Q3 24 | 0.01× | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $52.2M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | — | $46.6M |
| 自由现金流率自由现金流/营收 | — | 12.2% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | 3.74× | 4.93× |
| 过去12个月自由现金流最近4个季度 | — | $110.0M |
8季度趋势，按日历期对齐
经营现金流INVXLFST
| Q4 25 | $52.2M | $57.6M | ||
| Q3 25 | $48.4M | $27.3M | ||
| Q2 25 | $59.2M | $64.4M | ||
| Q1 25 | $31.1M | $-3.1M | ||
| Q4 24 | $36.3M | $62.3M | ||
| Q3 24 | $21.7M | $22.7M | ||
| Q2 24 | $22.8M | $44.1M | ||
| Q1 24 | $12.6M | $-21.8M |
自由现金流INVXLFST
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | $16.6M | $39.0M | ||
| Q1 24 | $7.8M | $-26.9M |
自由现金流率INVXLFST
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | 12.7% | 12.5% | ||
| Q1 24 | 6.1% | -9.0% |
资本支出强度INVXLFST
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | 4.7% | 1.6% | ||
| Q1 24 | 3.7% | 1.7% |
现金转化率INVXLFST
| Q4 25 | 3.74× | 4.93× | ||
| Q3 25 | 1.23× | 25.34× | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 2.11× | -4.36× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | 2.39× | — | ||
| Q1 24 | 0.77× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INVX
| Products | $202.7M | 74% |
| Leasing | $42.3M | 15% |
| Services | $28.6M | 10% |
LFST
暂无分部数据
